semaglutide vs tirzepatide vs retatrutide dosage vs. Tirzepatide: Dual vs. Triple Action, Doses, Benefits, Side Effects switching from to tirzepatide – Semaglutide vs. Tirzepatide vs. Retatrutide:

GLP2 once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

It targets GLP-1 and GIP, the same two hormones targeted by Lillys blockbuster drugs Mounjaro and Zepbound

Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs

The addition underscores Ros strategy of positioning itself as a one-stop shop for obesity care, blending telehealth consultations, insurance navigation and pharmacy services

People new to GLP-1 agonists If retatrutide is your first exposure to any GLP-1 receptor agonist, start at the lowest practical dose

Think of your gut like a garden